BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9043475)

  • 21. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
    Pech O; May A; Günter E; Gossner L; Ell C
    Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
    Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.
    Wijnhoven BP; Siersema PD; Hop WC; van Dekken H; Tilanus HW
    Br J Surg; 1999 Apr; 86(4):529-35. PubMed ID: 10215831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adenocarcinoma on endobrachyesophagus. Results and prognostic factors apropos of 19 cases surgically-treated].
    Michel C; Launoy G; Maurel J; Auvray S; Segol P; Gignoux M
    J Chir (Paris); 1992 Apr; 129(4):187-90. PubMed ID: 1527187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus.
    Zaninotto G; Parenti AR; Ruol A; Costantini M; Merigliano S; Ancona E
    Br J Surg; 2000 Aug; 87(8):1102-5. PubMed ID: 10931058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's oesophagus: results from a 13-year surveillance programme.
    Bani-Hani K; Sue-Ling H; Johnston D; Axon AT; Martin IG
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):649-54. PubMed ID: 10912484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of esophageal high-grade dysplasia.
    Reed MF; Tolis G; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ
    Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.
    Portale G; Hagen JA; Peters JH; Chan LS; DeMeester SR; Gandamihardja TA; DeMeester TR
    J Am Coll Surg; 2006 Apr; 202(4):588-96; discussion 596-8. PubMed ID: 16571425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
    Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
    Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.